Chromosomal aberrations in chronic lymphocytic leukemia detected by conventional cytogenetics with DSP30 as a single agent: Comparison with FISH

Leukemia Research

Volumn 35, Issue 8, 2011, Pages 1032-1038

  Kotkowska, Aleksandra ^a   Wawrzyniak, Ewa ^a,b   Blonski, Jerzy Z ^a,b   Robak, Tadeusz ^a,b   Korycka Wolowiec, Anna ^a,b  

^a POLISH MOTHER S MEMORIAL HOSPITAL RESEARCH INSTITUTE   (Poland)

^b MEDICAL UNIVERSITY OF LODZ   (Poland)

Author keywords

Chromosomal aberrations; Chronic lymphocytic leukemia; CpG oligonucleotide; Cytogenetics; DSP30; FISH

Indexed keywords

OLIGONUCLEOTIDE;

ADULT; AGED; ARTICLE; CHROMOSOME 11Q; CHROMOSOME 13Q; CHROMOSOME 2; CHROMOSOME 6; CHROMOSOME ABERRATION; CHROMOSOME ANALYSIS; CHROMOSOME DELETION; CHROMOSOME DELETION 13; CHROMOSOME TRANSLOCATION; CHRONIC LYMPHATIC LEUKEMIA; CONTROLLED STUDY; FEMALE; FLUORESCENCE IN SITU HYBRIDIZATION; HUMAN; INTERMETHOD COMPARISON; MAJOR CLINICAL STUDY; MALE; METAPHASE; PRIORITY JOURNAL; TRISOMY 12;

AGED; AGED, 80 AND OVER; CHROMOSOME ABERRATIONS; CYTOGENETIC ANALYSIS; FEMALE; HUMANS; IN SITU HYBRIDIZATION, FLUORESCENCE; LEUKEMIA, LYMPHOCYTIC, CHRONIC, B-CELL; MALE; MIDDLE AGED; OLIGONUCLEOTIDES; PROGNOSIS;

EID: 79960285669     PISSN: 01452126     EISSN: 18735835     Source Type: Journal    
DOI: 10.1016/j.leukres.2011.01.020     Document Type: Article

References (32)

1. Dighiero G., Hambli T.J. Chronic lymphocytic leukemia. Lancet 2008, 371:1017-1029.
2. Hallek M., Cheson B.D., Catovsky D., Caligaris-Cappio F., Dighiero G., Döhner H., et al. International Workshop on Chronic Lymphocytic Leukemia Guidelines for the diagnosis and treatment of chronic lymphocytic leukemia: a report from the International Workshop on Chronic Lymphocytic Leukemia updating the National Cancer Institute-Working Group 1996 guidelines. Blood 2008, 111:5446-5456.
3. Van Bockstaele F., Verhasselt B., Philippe J. Prognostic markers in chronic lymphocytic leukemia: a comprehensive review. Blood Rev 2009, 23:25-47.
4. Dohner H., Stilgenbauer S., Benner A., Leupolt E., Krober A., Bullinger L., et al. Genomic aberrations and survival in chronic lymphocytic leukemia. N Engl J Med 2000, 26:1910-1916.
5. Dewald G.W., Brockman S.R., Paternoster S.F., Bone N.D., O'Fallon J.R., Allmer C. Chromosome anomalies detected by interphase fluorescence in situ hybridization: correlation with significant biological features of B-cell chronic lymphocytic leukaemia. Br J Haematol 2003, 121:287-295.
6. Robak T., Blonski J.Z., Wawrzyniak E., Gora-Tybor J., Palacz A., Dmoszynska A., et al. Activity of cladribine combined with cyclophosphamide (CC regimen) in frontline therapy of chronic lymphocytic leukemia with 17p13.1/TP53 deletion; report from the Polish Adult Leukemia Group (PALG). Cancer 2009, 1:94-100.
7. Inamdar K.V., Bueso-Ramos C.E. Pathology of chronic lymphocytic leukemia: an update. Ann Diagn Pathol 2007, 11:363-389.
8. Juliusson G., Oscier D., Gahrton G. for the International Working Party On Chromosomes in CLL (IWCCLL) Cytogenetic findings and survival in B-cell chronic lymphocytic leukemia. Second IWCCLL compilation of date on 662 patients. Leuk Lymphoma 1991, 5:21-25.
9. Carlson M., Totterman T.H., Matsson P., Nilsson K. Cell cycle progression of B-chronic lymphocytic leukemia cells induced to differentiate by TPA. Blood 1988, 71:415-421.
10. Gahrton G., Robert K.H., Friberg K., Zech L., Bird A.G. Nonrandom chromosomal aberrations in chronic lymphocytic leukemia revealed by polyclonal B-cell mitogen stimulation. Blood 1980, 56:640-647.
11. El-Taweel M., Barin C., Cymbalista F., Eclache V. Detection of chromosomal abnormalities associated with chronic lymphocytic leukemia: what is the best method?. Cancer Genet Cytogenet 2009, 195:37-42.
12. Quintero-Rivera F., Nooraie F., Rao P.N. Frequency of 5′IGH deletion in B-cell chronic lymphocytic leukemia. Cancer Genet Cytogenet 2009, 190:33-39.
13. Gozzetti A., Le Beau M.M. Fluorescence in situ hybridization: uses and limitations. Semin Hematol 2000, 37:320-333.
14. Glassman A.B., Hayes K.J. The value of fluorescence in situ hybridization in the diagnosis of chronic lymphocytic leukemia. Cancer Genet Cytogenet 2005, 158:88-91.
15. Aoun P., Blair H.E., Smith L.M., Dave B.J., Lynch J., Weisenburger D.D., et al. Fluorescence in situ hybridization detection of cytogenetic abnormalities in B-cell chronic lymphocytic leukemia/small lymphocytic lymphoma. Leuk Lymphoma 2004, 45:1595-1603.
16. Decker T., Schneller F., Sparwasser T., Tretter T., Lipford G.B., Wagner H. Immunostimulatory CpG-oligonucleotides cause proliferation, cytokine production, and an immunogenic phenotype in chronic lymphocytic leukemia B cells. Blood 2000, 95:999-1006.
17. Sparwasser T., Koch E.S., Vabulas R.M., Heeg K., Lipford G.B., Ellwart J.W., et al. and immunostimulatory CpG oligonucleotides tigger maturation and activation of murine dendritic cells. Eur J Immunol 1998, 28:2045-2054.
18. Klinman D., Takeshita F., Gursel I., Leifer C., Ishii K.J., Verthelyi D., et al. CpG DNA: recognition by and activation of monocytes. Microbes Infect 2002, 4:897-901.
19. Decker T., Schneller F., Hipp S., Miething S., Jahn T., Duyster J., et al. Cell cycle progression of chronic lymphocytic leukemia cells is controlled by cyclin D2, cyclin D3, cyclin-dependent kinase (cdk) 4 and the cdk inhibitor p27. Leukemia 2002, 16:327-334.
20. Longo P.G., Laurenti L., Gobessi S., Petlickovski A., Pelosi M., Chiusolo P., et al. The Akt signaling pathway determines the different proliferative capacity of chronic lymphocytic leukemia B-cells from patients with progressive and stable disease. Leukemia 2007, 21:110-120.
21. H status, and CD38 expression. Blood 2006, 108:3152-3160.
22. H, status and immunophenotyping. Leukemia 2007, 21:2442-2451.
23. Mayr Ch., Speicher M.R., Kofler D.M., Buhmann R., Strehl J., Busch R. Chromosomal translocations are associated with poor prognosis in chronic lymphocytic leukaemia. Blood 2006, 107:742-751.
24. Put N., Konings P., Rack K., Jamar M., Van Roy N., Libouton J.M., et al. on behalf Belgian Cytogenetic Group for Hemato-Oncology (BCGHO). Improved detection of chromosomal abnormalities in chronic lymphocytic leukemia by conventional cytogenetics using CpG oligonucleotide and interleukin-2 stimulation: a Belgian multicentric study. Genes Chromosomes Cancer 2009, 48:843-853.
25. Wren C., Moriarty H., Marsden K., Tegg E. Cytogenetic investigations of chronic lymphocytic leukemia. Cancer Genet Cytogenet 2010, 198:155-161.
26. An international system for human cytogenetic nomenclature 2009, S Karger, Basel. L.G. Shaffer, M.L. Slovak, L.J. Campbell (Eds.).
27. Altman D.G. Practical statistics for medical research 1999, Champan Hall/CRC, London, pp. 403-409.
28. Stockero K.J., Fink S.R., Smoley S.A., Paternoster S.F., Shanafelt T.D., Call T.G., et al. Metaphase cells with normal G-bands have cryptic interstial deletions in 13q14 detectable by fluorescence in situ hybridization in B-cell chronic lymphocytic leukemia. Cancer Genet Cytogenet 2006, 166:152-156.
29. Fink S.R., Smoley S.A., Stockero K.J., Paternoster S.F., Thorland E.C., Van Dyke D.L., et al. Loss of TP53 is due to rearrangements involving chromosome region 17p10-p12 in chronic lymphocytic leukemia. Cancer Genet Cytogenet 2006, 167:177-181.
30. Schwaenen C., Nessling M., Wessendorf S., Salvi T., Wrobel G., Radlwimmer B., et al. Automated array-based genomic profiling in chronic lymphocytic leukemia: develop of a clinical tool and discovery of recurrent genomic alteration. Proc Natl Acad Sci USA 2004, 101:1039-1044.
31. Jarosova M., Urbankova H., Plachy, Papajik T., Holzerova M., Balcarkova J., et al. Gain of chromosome 2p in chronic lymphocytic leukemia: significant heterogeneity and a new recurrent dicentric rearrangement. Leuk Lymphoma 2010, 51:304-313.
32. Chapiro E., Leporrier N., Radford-Weiss I., Bastard C., Mossafa H., Leroux D., et al. Gain of the short arm of chromosome 2 (2p) is a frequent recurring chromosome aberration in untreated chronic lymphocytic leukemia (CLL) at advanced stages. Leuk Res 2010, 34:63-68.